186 related articles for article (PubMed ID: 34081952)
21. Prenatal Mechanistic Target of Rapamycin Complex 1 (m TORC1) Inhibition by Rapamycin Treatment of Pregnant Mice Causes Intrauterine Growth Restriction and Alters Postnatal Cardiac Growth, Morphology, and Function.
Hennig M; Fiedler S; Jux C; Thierfelder L; Drenckhahn JD
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28778941
[TBL] [Abstract][Full Text] [Related]
22. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
[TBL] [Abstract][Full Text] [Related]
23. Amino Acid-Mediated Intracellular Ca
Amemiya Y; Nakamura N; Ikeda N; Sugiyama R; Ishii C; Maki M; Shibata H; Takahara T
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34198993
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of various genetic mouse models of the mechanistic target of rapamycin complex I inhibition on heart failure.
Dai DF; Liu Y; Basisty N; Karunadharma P; Dastidar SG; Chiao YA; Chen T; Beyer RP; Chin MT; Maccoss M; La Spada AR; Rabinovitch PS
Geroscience; 2019 Dec; 41(6):847-860. PubMed ID: 31650481
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA302-367-PI3K-PTEN-AKT-mTORC1 pathway promotes the development of cardiac hypertrophy through controlling autophagy.
Jin L; Zhou Y; Han L; Piao J
In Vitro Cell Dev Biol Anim; 2020 Feb; 56(2):112-119. PubMed ID: 31845077
[TBL] [Abstract][Full Text] [Related]
26. mTOR Hyperactivation by Ablation of Tuberous Sclerosis Complex 2 in the Mouse Heart Induces Cardiac Dysfunction with the Increased Number of Small Mitochondria Mediated through the Down-Regulation of Autophagy.
Taneike M; Nishida K; Omiya S; Zarrinpashneh E; Misaka T; Kitazume-Taneike R; Austin R; Takaoka M; Yamaguchi O; Gambello MJ; Shah AM; Otsu K
PLoS One; 2016; 11(3):e0152628. PubMed ID: 27023784
[TBL] [Abstract][Full Text] [Related]
27. mTORC1 activation in lung mesenchyme drives sex- and age-dependent pulmonary structure and function decline.
Obraztsova K; Basil MC; Rue R; Sivakumar A; Lin SM; Mukhitov AR; Gritsiuta AI; Evans JF; Kopp M; Katzen J; Robichaud A; Atochina-Vasserman EN; Li S; Carl J; Babu A; Morley MP; Cantu E; Beers MF; Frank DB; Morrisey EE; Krymskaya VP
Nat Commun; 2020 Nov; 11(1):5640. PubMed ID: 33159078
[TBL] [Abstract][Full Text] [Related]
28. Rapamycin prevents thyroid hormone-induced cardiac hypertrophy.
Kuzman JA; O'Connell TD; Gerdes AM
Endocrinology; 2007 Jul; 148(7):3477-84. PubMed ID: 17395699
[TBL] [Abstract][Full Text] [Related]
29. Dampened VEPH1 activates mTORC1 signaling by weakening the TSC1/TSC2 association in hepatocellular carcinoma.
Dong P; Wang X; Liu L; Tang W; Ma L; Zeng W; Sun S; Zhang L; Zhang N; Shen X; Janssen HLA; Dong L; Zhang S; Chen S
J Hepatol; 2020 Dec; 73(6):1446-1459. PubMed ID: 32610114
[TBL] [Abstract][Full Text] [Related]
30. Hyperactivation of mTORC1 disrupts cellular homeostasis in cerebellar Purkinje cells.
Sakai Y; Kassai H; Nakayama H; Fukaya M; Maeda T; Nakao K; Hashimoto K; Sakagami H; Kano M; Aiba A
Sci Rep; 2019 Feb; 9(1):2799. PubMed ID: 30808980
[TBL] [Abstract][Full Text] [Related]
31. Novel mTORC1 Mechanism Suggests Therapeutic Targets for COMPopathies.
Posey KL; Coustry F; Veerisetty AC; Hossain MG; Gambello MJ; Hecht JT
Am J Pathol; 2019 Jan; 189(1):132-146. PubMed ID: 30553437
[TBL] [Abstract][Full Text] [Related]
32. Substrate metabolism regulated by Sestrin2-mTORC1 alleviates pressure overload-induced cardiac hypertrophy in aged heart.
Quan N; Li X; Zhang J; Han Y; Sun W; Ren D; Tong Q; Li J
Redox Biol; 2020 Sep; 36():101637. PubMed ID: 32863202
[TBL] [Abstract][Full Text] [Related]
33. Ablation of TSC2 enhances insulin secretion by increasing the number of mitochondria through activation of mTORC1.
Koyanagi M; Asahara S; Matsuda T; Hashimoto N; Shigeyama Y; Shibutani Y; Kanno A; Fuchita M; Mikami T; Hosooka T; Inoue H; Matsumoto M; Koike M; Uchiyama Y; Noda T; Seino S; Kasuga M; Kido Y
PLoS One; 2011; 6(8):e23238. PubMed ID: 21886784
[TBL] [Abstract][Full Text] [Related]
34. Decreased rates of cerebral protein synthesis measured in vivo in a mouse model of Tuberous Sclerosis Complex: unexpected consequences of reduced tuberin.
Saré RM; Huang T; Burlin T; Loutaev I; Smith CB
J Neurochem; 2018 Jun; 145(5):417-425. PubMed ID: 29364507
[TBL] [Abstract][Full Text] [Related]
35. Fetal brain mTOR signaling activation in tuberous sclerosis complex.
Tsai V; Parker WE; Orlova KA; Baybis M; Chi AW; Berg BD; Birnbaum JF; Estevez J; Okochi K; Sarnat HB; Flores-Sarnat L; Aronica E; Crino PB
Cereb Cortex; 2014 Feb; 24(2):315-27. PubMed ID: 23081885
[TBL] [Abstract][Full Text] [Related]
36. Saraf-dependent activation of mTORC1 regulates cardiac growth.
Sanlialp A; Schumacher D; Kiper L; Varma E; Riechert E; Ho TC; Hofmann C; Kmietczyk V; Zimmermann F; Dlugosz S; Wirth A; Gorska AA; Burghaus J; Camacho Londoño JE; Katus HA; Doroudgar S; Freichel M; Völkers M
J Mol Cell Cardiol; 2020 Apr; 141():30-42. PubMed ID: 32173353
[TBL] [Abstract][Full Text] [Related]
37. The E3 ubiquitin ligase Peli1 regulates the metabolic actions of mTORC1 to suppress antitumor T cell responses.
Ko CJ; Zhang L; Jie Z; Zhu L; Zhou X; Xie X; Gao T; Yang JY; Cheng X; Sun SC
EMBO J; 2021 Jan; 40(2):e104532. PubMed ID: 33215753
[TBL] [Abstract][Full Text] [Related]
38. Early activation of mTORC1 signalling in response to mechanical overload is independent of phosphoinositide 3-kinase/Akt signalling.
Miyazaki M; McCarthy JJ; Fedele MJ; Esser KA
J Physiol; 2011 Apr; 589(Pt 7):1831-46. PubMed ID: 21300751
[TBL] [Abstract][Full Text] [Related]
39. AMPK inhibits cardiac hypertrophy by promoting autophagy via mTORC1.
Li Y; Chen C; Yao F; Su Q; Liu D; Xue R; Dai G; Fang R; Zeng J; Chen Y; Huang H; Ma Y; Li W; Zhang L; Liu C; Dong Y
Arch Biochem Biophys; 2014 Sep; 558():79-86. PubMed ID: 25009141
[TBL] [Abstract][Full Text] [Related]
40. Dual targeting of androgen receptor and mTORC1 by salinomycin in prostate cancer.
Mirkheshti N; Park S; Jiang S; Cropper J; Werner SL; Song CS; Chatterjee B
Oncotarget; 2016 Sep; 7(38):62240-62254. PubMed ID: 27557496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
